Roxanne Croze

Senior Director, Vector Innovation

Role: Senior Director, Vector Innovation at 4D Molecular Therapeutics
Location: Oakland, CA, US
LinkedIn followers: 500 followers

Research & DevelopmentView LinkedIn profile

About Roxanne Croze

Experienced Scientist with a demonstrated history of working in the biotechnology…

Experience

Senior Director, Vector Innovation
4D Molecular Therapeutics
Sep 2023 — Present

Education

University of California, Santa Barbara
Doctor of Philosophy (Ph.D.)
2010 — 2015
UCSB
Master of Arts (M.A.)
2010 — 2012
University of California, Davis
BS
2003 — 2007

Skills

Cell Culture
Lifesciences
Pcr
Western Blotting
Cell Biology
Life Sciences
Cell
Data Analysis
Polymerase Chain Reaction (Pcr)
Molecular Cloning
Science
Microscopy
Biochemistry
Molecular Biology
Fluorescence Microscopy
Research

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@4dmoleculartherapeutics.com
Personal email
•••••@•••••.com
Direct dial
+19•••••••82

Unlock verified contacts

Free to start · No credit card required

Current company

4D Molecular Therapeutics

Biotechnology Research · 217 employees · Founded 2013 · Emeryville, California, United States

4DMT is a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. The Company’s lead product candidate 4D-150 is designed to be a backbone therapy forming the foundation of treatment of blinding retinal vascular diseases by providing multi-year sustained delivery of anti-VEGF biologics (aflibercept and anti-VEGF-C) with a single intravitreal injection, which substantially reduces the treatment burden associated with current bolus injections. The Company’s lead indication for 4D-150 is wet age-related macular degeneration, which is currently in Phase 3 development, and second indication is diabetic macular edema. The Company’s second product candidate is 4D-710, which is the first known genetic medicine to demonstrate successful delivery and expression of the CFTR transgene in the lungs of people with cystic fibrosis after aerosol delivery. We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our Core Values drive the way we work together: - Dare to Cure - Break Boundaries - Beyond Yourself - Prepare & Execute Relentlessly Join us in creating the future of genetic medicine.

4dmoleculartherapeutics.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Roxanne Croze

Experience

Senior Director, Vector Innovation

Education

University of California, Santa Barbara

UCSB

University of California, Davis

Skills

Find verified contacts for anyone on LinkedIn